Key Drivers
- Solid annual earnings
- Quarterly FCF pressure
- Large intangibles
AIAI Summary
ELV's investment thesis has shifted from membership-led growth to an execution-driven capital-allocation story where near‑term EPS re‑rating hinges on restoring consistent quarterly free cash flow and proving Carelon/digital cost savings can offset steep Medicaid-related margin headwinds; monitor sequential quarterly FCF, Medicaid membership/margin trends, and timely MA/Star improvements as make‑or‑break catalysts. If FCF and margin recovery materialize alongside clear Carelon operational leverage, upside is credible; failure to deliver would likely force multiple compression and potential impairments.
Price Chart
Financial Metrics
Deep Analysis
Research tool. Not personalized advice.
Fundamental Analysis
Key Financial Insights:
- •Solid annual earnings
- •Quarterly FCF pressure
- •Large intangibles
Elanco is a reasonably valued, dividend‑paying animal-health company with solid annual earnings, ample cash and manageable leverage but notable near-term risk from deteriorating quarterly margins, negative quarterly FCF and a large intangible asset base.
Price Behavior
Key Price Behavior Insights:
- •Below last-month SMA
- •Support near $279
- •Resistance $320–$375
ELV is trading below its last-month SMA (~$300), indicating a short-term downtrend with nearby support at $279.02 and stronger resistance in the $320–$375 band after a ~14% drop from late February.
~14% decline from ~2026-02-20 to 2026-03-20 indicating short-term distribution
Sentiment & News
Key News Insights:
- •Mixed institutional activity
- •Rising short interest
- •Legal/investor alerts
Institutional flows into Elevance Health surged in late Feb–mid Mar 2026 with several new and increased stakes offset by large manager trims, a sharp 29.3% rise in short interest, ongoing legal/investor alerts, and an overall “Moderate Buy” analyst consensus.
Elevated trading activity and increased shorting heighten near-term volatility risk despite modest analyst optimism
Similar Companies in Healthcare
Other companies in the same sector with AI ratings